Your browser doesn't support javascript.
loading
Normal ex vivo mesenchymal stem cell function combined with abnormal immune profiles sets the stage for informative cell therapy trials in idiopathic pulmonary fibrosis patients.
Atanasova, Elena; Milosevic, Dragana; Bornschlegl, Svetlana; Krucker, Karen P; Jacob, Eapen K; Carmona Porquera, Eva M; Anderson, Dagny K; Egan, Ashley M; Limper, Andrew H; Dietz, Allan B.
Afiliação
  • Atanasova E; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Milosevic D; Department of Laboratory Medicine and Pathology, Divisions of Clinical Biochemistry and Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Bornschlegl S; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Krucker KP; Divisions of Transfusion Medicine and Experimental Pathology, Immune Progenitor and Cell Therapeutics (IMPACT) Lab, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Jacob EK; Division of Transfusion Medicine, Mayo Clinic, Rochester, MN, USA.
  • Carmona Porquera EM; Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Anderson DK; Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Egan AM; Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Limper AH; Thoracic Diseases Research Unit, Division of Pulmonary Critical Care and Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN, USA.
  • Dietz AB; Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, MN, USA. Dietz.allan@mayo.edu.
Stem Cell Res Ther ; 13(1): 45, 2022 01 31.
Article em En | MEDLINE | ID: mdl-35101101

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrose Pulmonar Idiopática / Células-Tronco Mesenquimais Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos